Damora Therapeutics, Inc. (DMRA)
Market Closed
26 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (CM) Primary NASDAQ (NMS) $
21. 26
+0.17
+0.8061%
After Hours
$
+4.74 +22.2954% 26. 00
- Market Cap
- P/E Ratio
- Div Yield
641,718 Volume
- Eps
$ 21.09
Previous Close 
Want to track DMRA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Damora Therapeutics, Inc. (DMRA) Statistics
Valuation metrics
Market Cap -
Enterprise value 761.49M
Trailing P/E (ttm) -0.17
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 2.5
Enterprise Value/Revenue -
Enterprise Value/EBITDA -2.86
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 433.86K
Average volume (90 days) 522.35K
Price summary
52-Week low 4.95
52-Week high 38.33
Beta -
50-Day moving average 22.11
200-Day moving average 25.55
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 30 Aug 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.48%
Return on equity -0.83%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -4.3
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 8.84
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 19.73%
Book value per share (mrq) 8.44
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
